Latest Insider Transactions at Syndax Pharmaceuticals Inc (SNDX)
This section provides a real-time view of insider transactions for Syndax Pharmaceuticals Inc (SNDX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Syndax Pharmaceuticals Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Syndax Pharmaceuticals Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 01
2020
|
Michael A Metzger Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+31.47%
|
$105,000
$7.2 P/Share
|
|
Nov 23
2020
|
Peter Ordentlich Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
29,972
-50.57%
|
$689,356
$23.27 P/Share
|
|
Nov 23
2020
|
Peter Ordentlich Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,972
+32.97%
|
$89,916
$3.08 P/Share
|
|
Nov 10
2020
|
Briggs Morrison |
SELL
Open market or private sale
|
Direct |
17,466
-27.28%
|
$349,320
$20.06 P/Share
|
|
Nov 10
2020
|
Briggs Morrison |
BUY
Exercise of conversion of derivative security
|
Direct |
17,466
+21.43%
|
$122,262
$7.2 P/Share
|
|
Nov 09
2020
|
Briggs Morrison |
SELL
Open market or private sale
|
Direct |
62,938
-57.48%
|
$1,258,760
$20.04 P/Share
|
|
Nov 09
2020
|
Briggs Morrison |
BUY
Exercise of conversion of derivative security
|
Direct |
62,938
+36.5%
|
$440,566
$7.2 P/Share
|
|
Nov 04
2020
|
Michael A Metzger Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
100,000
-84.99%
|
$2,000,000
$20.31 P/Share
|
|
Nov 04
2020
|
Michael A Metzger Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+45.94%
|
$700,000
$7.2 P/Share
|
|
Jul 31
2020
|
Michael L. Meyers SVP, Chief Medical Officer |
BUY
Other acquisition or disposition
|
Direct |
2,665
+16.59%
|
$18,655
$7.97 P/Share
|
|
Jun 18
2018
|
Bvf Partners L P > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
2,000,000
-68.94%
|
-
|